Home
Site Map
Press Room
Press Releases
Contact Us
Clinical Trials
Phase 3 — Hepatocellular Carcinoma (HCC)
Phase 3 — Metastatic Colorectal Cancer (MCRC)
Phase 2 — Benign Prostatic Hyperplasia (BPH)
Phase 1 — Benign Prostatic Hyperplasia (BPH)
Pipeline
Hepatocellular Carcinoma (HCC)
Metastatic Colorectal Cancer (MCRC)
Glioma
Benign Prostatic Hyperplasia (BPH)
Aptocine™
Aptocine™ Advantages
Publications
The Company
Executive Team
Board of Directors
Scientific Advisory Board
Careers
Contact LSO
Press Room
Press Releases
Contact Us
Press Releases
View Archive: 2010 |
2009
|
2008
|
2007
|
2006
|
2005
February 25, 2010 –
Light Sciences Oncology Meets a Major Milestone in Aptocine Development with Target Enrollment in Phase 3 MCRC Trial
